Literature DB >> 2578237

A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.

C Sorg, E B Bröcker, G Zwadlo, K Redmann, U Feige, W Ax, A C Feller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578237

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Inflammatory reactions in primary osteoarthritis of the hip and total hip prosthesis loosening.

Authors:  B Greitemann; B Mues; J Polster; T Pauly; C Sorg
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

2.  Biological characterization of human bone tumors. X. The proliferation behavior of macrophages as compared to fibroblastic cells in malignant fibrous histiocytoma and giant cell tumor of bone.

Authors:  A Roessner; J Vassallo; E Vollmer; G Zwadlo; C Sorg; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Induction of procoagulant activity in human epidermal cells.

Authors:  A Schöne; E Zimmermann; J Knop
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Metastatic human melanoma. Phenotypic heterogeneity and antigen expression in relation to the clinical status.

Authors:  L Suter; E B Bröcker; H Ostmeier; J Schumann; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Alteration in the pattern of macrophage subtypes in chronic osteomyelitis compared with acute joint infection.

Authors:  K M Peters; K Koberg; T Rosendahl; W Schmutzler; G Zwadlo-Klarwasser
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

6.  Pattern of macrophage subpopulations in post-traumatic bone infections after combined operative/antibiotic treatment.

Authors:  K M Peters; T Rosendahl; K W Zilkens; G Zwadlo-Klarwasser
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

7.  Biological characterization of human bone tumors. VIII. Expression of HLA-DR antigens in bone tumors and tumor-like lesions.

Authors:  M Petzsch; J Vassallo; A Roessner; G Zwadlo; C Sorg; E Vollmer; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors?

Authors:  E B Bröcker; L Suter; B M Czarnetzki; E Macher
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.